- Home
- DHC vs KURA Comparison
DHC vs KURA Comparison
Compare DHC & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHC
- KURA
- Stock Information
- Founded
- DHC 1998
- KURA 2014
- Country
- DHC United States
- KURA United States
- Employees
- DHC N/A
- KURA N/A
- Industry
- DHC Real Estate Investment Trusts
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DHC Real Estate
- KURA Health Care
- Exchange
- DHC Nasdaq
- KURA Nasdaq
- Market Cap
- DHC 856.4M
- KURA 884.1M
- IPO Year
- DHC N/A
- KURA N/A
- Fundamental
- Price
- DHC $4.58
- KURA $11.24
- Analyst Decision
- DHC Buy
- KURA Strong Buy
- Analyst Count
- DHC 2
- KURA 13
- Target Price
- DHC $5.25
- KURA $25.40
- AVG Volume (30 Days)
- DHC 886.9K
- KURA 2.4M
- Earning Date
- DHC 11-03-2025
- KURA 11-04-2025
- Dividend Yield
- DHC 0.87%
- KURA N/A
- EPS Growth
- DHC N/A
- KURA N/A
- EPS
- DHC N/A
- KURA N/A
- Revenue
- DHC $1,537,901,000.00
- KURA $104,029,000.00
- Revenue This Year
- DHC $4.05
- KURA $68.63
- Revenue Next Year
- DHC $3.08
- KURA $141.59
- P/E Ratio
- DHC N/A
- KURA N/A
- Revenue Growth
- DHC 4.10
- KURA N/A
- 52 Week Low
- DHC $2.00
- KURA $5.41
- 52 Week High
- DHC $4.99
- KURA $16.68
- Technical
- Relative Strength Index (RSI)
- DHC 59.35
- KURA 62.91
- Support Level
- DHC $4.49
- KURA $9.51
- Resistance Level
- DHC $4.99
- KURA $12.49
- Average True Range (ATR)
- DHC 0.22
- KURA 0.95
- MACD
- DHC 0.03
- KURA 0.06
- Stochastic Oscillator
- DHC 61.32
- KURA 65.63
About DHC Diversified Healthcare Trust of Beneficial Interest
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs. Majority of revenue is from SHOP segment.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.